8-38417331-G-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_023110.3(FGFR1):c.1638C>A(p.Asn546Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
FGFR1
NM_023110.3 missense
NM_023110.3 missense
Scores
8
9
2
Clinical Significance
Conservation
PhyloP100: 2.11
Genes affected
FGFR1 (HGNC:3688): (fibroblast growth factor receptor 1) The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds both acidic and basic fibroblast growth factors and is involved in limb induction. Mutations in this gene have been associated with Pfeiffer syndrome, Jackson-Weiss syndrome, Antley-Bixler syndrome, osteoglophonic dysplasia, and autosomal dominant Kallmann syndrome 2. Chromosomal aberrations involving this gene are associated with stem cell myeloproliferative disorder and stem cell leukemia lymphoma syndrome. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 17 ACMG points.
PM1
In a domain Protein kinase (size 289) in uniprot entity FGFR1_HUMAN there are 78 pathogenic changes around while only 2 benign (98%) in NM_023110.3
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), FGFR1. . Gene score misZ: 2.4852 (greater than the threshold 3.09). Trascript score misZ: 4.2642 (greater than threshold 3.09). The gene has 93 curated pathogenic missense variants (we use a threshold of 10). The gene has 28 curated benign missense variants. GenCC has associacion of the gene with hypogonadotropic hypogonadism 2 with or without anosmia, encephalocraniocutaneous lipomatosis, hypogonadotropic hypogonadism, tooth agenesis, isolated trigonocephaly, Pfeiffer syndrome type 1, Jackson-Weiss syndrome, Pfeiffer syndrome, Kallmann syndrome, septooptic dysplasia, hypogonadotropic hypogonadism 7 with or without anosmia, holoprosencephaly, osteoglophonic dwarfism, Hartsfield-Bixler-Demyer syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.94
PP5
Variant 8-38417331-G-T is Pathogenic according to our data. Variant chr8-38417331-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 224896.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-38417331-G-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFR1 | ENST00000447712.7 | c.1638C>A | p.Asn546Lys | missense_variant | 12/18 | 1 | NM_023110.3 | ENSP00000400162.2 | ||
FGFR1 | ENST00000397091.9 | c.1632C>A | p.Asn544Lys | missense_variant | 12/18 | 1 | ENSP00000380280.5 | |||
FGFR1 | ENST00000397108.8 | c.1632C>A | p.Asn544Lys | missense_variant | 13/19 | 1 | ENSP00000380297.4 | |||
FGFR1 | ENST00000397113.6 | c.1632C>A | p.Asn544Lys | missense_variant | 12/18 | 2 | ENSP00000380302.2 | |||
FGFR1 | ENST00000356207.9 | c.1371C>A | p.Asn457Lys | missense_variant | 11/17 | 1 | ENSP00000348537.5 | |||
FGFR1 | ENST00000397103.5 | c.1371C>A | p.Asn457Lys | missense_variant | 10/16 | 5 | ENSP00000380292.1 | |||
FGFR1 | ENST00000326324.10 | c.1365C>A | p.Asn455Lys | missense_variant | 11/17 | 1 | ENSP00000327229.6 | |||
FGFR1 | ENST00000487647.5 | n.*1329C>A | non_coding_transcript_exon_variant | 11/12 | 1 | ENSP00000435254.1 | ||||
FGFR1 | ENST00000487647.5 | n.*1329C>A | 3_prime_UTR_variant | 11/12 | 1 | ENSP00000435254.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Encephalocraniocutaneous lipomatosis Pathogenic:3Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 11, 2016 | - - |
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | May 25, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | - | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Rosette-forming glioneuronal tumor Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Donald Williams Parsons Laboratory, Baylor College of Medicine | - | - - |
Neoplasm Other:1
-, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Jul 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
.;.;D;.;.;.;.;.;D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D;.;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;.;N;.;.;.;.;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D;D;D;D;D;D;D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D;D;D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D;D;D;D;D;D
Polyphen
1.0
.;.;D;D;.;.;D;D;.;.
Vest4
MutPred
0.77
.;.;Gain of methylation at N546 (P = 0.0047);.;.;.;.;.;.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at